A novel cell permeable DNA replication and repair marker

Nucleus

Volumn 5, Issue 6, 2014, Pages 590-600

  Herce, Henry D ^a   Rajan, Malini ^a   Lättig Tünnemann, Gisela ^b   Fillies, Marion ^b   Cardoso, M Cristina ^a  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cell cycle; Cell penetrating peptides; DNA repair; DNA replication; PCNA; Proliferating cell nuclear antigen

Indexed keywords

BIOLOGICAL MARKER; CELL PENETRATING PEPTIDE; CYCLINE; FLUORESCENT DYE; HYBRID PROTEIN; POGO; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN; PROTEIN P21; REPAIR MARKER; TRANSACTIVATOR PROTEIN; TRANSPOSASE; UNCLASSIFIED DRUG; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; CELL LABELING; CELL MEMBRANE PERMEABILITY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IRRADIATION; MOLECULAR DYNAMICS; NONHUMAN; PLASMID; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; 3T3 CELL LINE; ANIMAL; CELL CYCLE; CHEMISTRY; GENETICS; HAMSTER; HELA CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOUSE; PROTEIN CONFORMATION;

CRICETINAE; HUMAN IMMUNODEFICIENCY VIRUS 1;

3T3 CELLS; ANIMALS; CELL CYCLE; CELL-PENETRATING PEPTIDES; CRICETINAE; DNA REPAIR; DNA REPLICATION; HELA CELLS; HIV-1; HUMANS; MICE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; PROTEIN CONFORMATION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84921929020     PISSN: 19491034     EISSN: 19491042     Source Type: Journal    
DOI: 10.4161/nucl.36290     Document Type: Article

References (39)

1. Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 2003; 116:3051-60; PMID:12829735; http://dx.doi.org/10.1242/jcs.00653
2. Görisch SM, Sporbert A, Stear JH, Grunewald I, Nowak D, Warbrick E, Leonhardt H, Cardoso MC. Uncoupling the replication machinery: replication fork progression in the absence of processive DNA synthesis. Cell Cycle 2008; 7:1983-90; PMID:18604168; http://dx.doi.org/10.4161/cc.7.13.6094
3. Paunesku T, Mittal S, Proti_c M, Oryhon J, Korolev SV, Joachimiak A, Woloschak GE. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol 2001; 77:1007-21; PMID:11682006; http://dx.doi.org/10.1080/09553000110069335
4. Fan J, Otterlei M, Wong HK, Tomkinson AE, Wilson DM. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res 2004; 32:2193-201; PMID:15107487; http://dx.doi.org/10.1093/nar/gkh556
5. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326:515-7; PMID: 2882423; http://dx.doi.org/10.1038/326515a0
6. Moldovan GL, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell 2007; 129:665-79; PMID:17512402; http://dx.doi.org/10.1016/j.cell.2007. 05.003
7. Fridman Y, Palgi N, Dovrat D, Ben-Aroya S, Hieter P, Aharoni A. Subtle alterations in PCNA-partner interactions severely impair DNA replication and repair. PLoS Biol 2010; 8:e1000507; PMID:20967232; http://dx.doi.org/10.1371/journal.pbio.1000507
8. Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regulation of PCNA-protein interactions for genome stability. Nat Rev Mol Cell Biol 2013; 14:269-82; PMID:23594953; http://dx.doi.org/10.1038/nrm3562
9. Trimis G, Chatzistamou I, Politi K, Kiaris H, Papavassiliou AG. Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors. Hum Mol Genet 2008; 17:3596-600; PMID:18713757; http://dx.doi.org/10.1093/hmg/ddn252
10. Ball KL, Lain S, Fahraeus R, Smythe C, Lane DP. Cellcycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1. Curr Biol 1997; 7:71-80; PMID:8999999; http://dx.doi.org/10.1016/S0960-9822(06)00029-7
11. Warbrick E, Lane DP, Glover DM, Cox LS. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr Biol 1995; 5:275-82; PMID:7780738; http://dx.doi.org/10.1016/S0960-9822(95)00058-3
12. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1:639-49; PMID:12479224
13. Tünnemann G, Martin RM, Haupt S, Patsch C, Edenhofer F, Cardoso MC. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J 2006; 20:1775-84; PMID:16940149; http://dx.doi.org/10.1096/fj.05-5523com
14. Cardoso MC, Leonhardt H, Nadal-Ginard B. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 1993; 74:979-92; PMID:8402887; http://dx.doi.org/10.1016/0092-8674(93)90721-2
15. Cardoso MC, Joseph C, Rahn HP, Reusch R, Nadal-Ginard B, Leonhardt H. Mapping and use of a sequence that targets DNA ligase I to sites of DNA replication in vivo. J Cell Biol 1997; 139:579-87; PMID:9348276; http://dx.doi.org/10.1083/jcb.139. 3.579
16. Easwaran HP, Leonhardt H, Cardoso MC. Cell cycle markers for live cell analyses. Cell Cycle 2005; 4:453-5; PMID:15701967; http://dx.doi.org/10.4161/cc.4.3. 1525
17. Chagin VO, Stear JH, Cardoso MC. Organization of DNA replication. Cold Spring Harb Perspect Biol 2010; 2:a000737; PMID:20452942; http://dx.doi.org/10.1101/cshperspect.a000737
18. Warbrick E, Heatherington W, Lane DP, Glover DM. PCNA binding proteins in Drosophila melanogaster: the analysis of a conserved PCNA binding domain. Nucleic Acids Res 1998; 26:3925-32; PMID:9705499; http://dx.doi.org/10.1093/nar/26.17.3925
19. Kontopidis G, Wu SY, Zheleva DI, Taylor P, McInnes C, Lane DP, Fischer PM, Walkinshaw MD. Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci U S A 2005; 102:1871-6; PMID:15681588; http://dx.doi.org/10.1073/pnas.0406540102
20. Zheleva DI, Zhelev NZ, Fischer PM, Duff SV, Warbrick E, Blake DG, Lane DP. A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics. Biochemistry 2000; 39:7388-97; PMID:10858286; http://dx.doi.org/10.1021/bi992498r
21. Gulbis JM, Kelman Z, Hurwitz J, O’Donnell M, Kuriyan J. Structure of the C-terminal region of p21 (WAF1/CIP1) complexed with human PCNA. Cell 1996; 87:297-306; PMID:8861913; http://dx.doi.org/10.1016/S0092-8674(00)81347-1
22. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988; 55:1189-93; PMID:2849510; http://dx.doi.org/10.1016/0092-8674(88)90263-2
23. Herce HD, Garcia AE. Cell penetrating peptides: how do they do it? J Biol Phys 2007; 33:345-56; PMID:19669523; http://dx.doi.org/10.1007/s10867-008-9074-3
24. Lättig-Tünnemann G, Prinz M, Hoffmann D, Behlke J, Palm-Apergi C, Morano I, Herce HD, Cardoso MC. Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides. Nat Commun 2011; 2:453; PMID:21878907; http://dx.doi.org/10.1038/ncomms1459
25. Herce HD, Deng W, Helma J, Leonhardt H, Cardoso MC. Visualization and targeted disruption of protein interactions in living cells. Nat Commun 2013; 4:2660; PMID:24154492; http://dx.doi.org/10.1038/ncomms3660
26. Martin RM, Tünnemann G, Leonhardt H, Cardoso MC. Nucleolar marker for living cells. Histochem Cell Biol 2007; 127:243-51; PMID:17205309; http://dx.doi.org/10.1007/s00418-006-0256-4
27. Nischan N, Chakrabarti A, Serwa RA, Bovee-Geurts PH, Brock R, Hackenberger CP. Stabilization of peptides for intracellular applications by phosphoramidatelinked polyethylene glycol chains. Angew Chem Int Ed Engl 2013; 52:11920-4; PMID:24039043; http://dx.doi.org/10.1002/anie.201303467
28. Havens CG, Walter JC. Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Genes Dev 2011; 25:1568-82; PMID:21828267; http://dx.doi.org/10.1101/gad.2068611
29. Tsanov N, Kermi C, Coulombe P, Van der Laan S, Hodroj D, Maiorano D. PIP degron proteins, substrates of CRL4Cdt2, and not PIP boxes, interfere with DNA polymerase h and k focus formation on UV damage. Nucleic Acids Res 2014; 42:3692-706; PMID:24423875; http://dx.doi.org/10.1093/nar/gkt1400
30. Gilljam KM, Feyzi E, Aas PA, Sousa MM, Müller R, Vágbø CB, Catterall TC, Liabakk NB, Slupphaug G, Drabløs F, et al. Identification of a novel, widespread, and functionally important PCNA-binding motif. J Cell Biol 2009; 186:645-54; PMID:19736315; http://dx.doi.org/10.1083/jcb.200903138
31. Müller R, Misund K, Holien T, Bachke S, Gilljam KM, Vátsveen TK, Rø TB, Bellacchio E, Sundan A, Otterlei M. Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells. PLoS One 2013; 8:e70430; PMID:23936203; http://dx.doi.org/10.1371/journal. pone.0070430
32. Leonhardt H, Rahn HP, Weinzierl P, Sporbert A, Cremer T, Zink D, Cardoso MC. Dynamics of DNA replication factories in living cells. J Cell Biol 2000; 149:271-80; PMID:10769021; http://dx.doi.org/10.1083/jcb.149.2.271
33. Sporbert A, Domaing P, Leonhardt H, Cardoso MC. PCNA acts as a stationary loading platform for transiently interacting Okazaki fragment maturation proteins. Nucleic Acids Res 2005; 33:3521-8; PMID:15972794; http://dx.doi.org/10.1093/nar/gki665
34. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977; 270:725-7; PMID:563524; http://dx.doi.org/10.1038/270725a0
35. Tsukamoto T, Hashiguchi N, Janicki SM, Tumbar T, Belmont AS, Spector DL. Visualization of gene activity in living cells. Nat Cell Biol 2000; 2:871-8; PMID:11146650; http://dx.doi.org/10.1038/35046510
36. Casas-Delucchi CS, Becker A, Bolius JJ, Cardoso MC. Targeted manipulation of heterochromatin rescues MeCP2 Rett mutants and re-establishes higher order chromatin organization. Nucleic Acids Res 2012; 40: e176; PMID:22923521; http://dx.doi.org/10.1093/nar/gks784
37. Pronk S, P_all S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, van der Spoel D, et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 2013; 29:845-54; PMID:23407358; http://dx.doi.org/10.1093/bioinformatics/btt055
38. Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, Shaw DE. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 2010; 78:1950-8; PMID:20408171
39. Mortusewicz O, Leonhardt H. XRCC1 and PCNA are loading platforms with distinct kinetic properties and different capacities to respond to multiple DNA lesions. BMC Mol Biol 2007; 8:81; PMID:17880707; http://dx.doi.org/10.1186/1471-2199-8-81